Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Medtronic
Baxter
Moodys
Merck

Last Updated: January 26, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for GDC-0853


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug GDC-0853?

GDC-0853 is an investigational drug.

There have been 184 clinical trials for GDC-0853. The most recent clinical trial was a Phase 3 trial, which was initiated on March 17th 2014.

The most common disease conditions in clinical trials are Breast Neoplasms, Carcinoma, and Lymphoma. The leading clinical trial sponsors are Genentech, Inc., National Cancer Institute (NCI), and Hoffmann-La Roche.

There are eight US patents protecting this investigational drug and one hundred and twenty-nine international patents.

Recent Clinical Trials for GDC-0853
TitleSponsorPhase
Testing the Safety and Efficacy of the Addition of A New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Etoposide and Cisplatin) for Adult and Pediatric Patients (12-17 Years) With NUT CarcinomaNational Cancer Institute (NCI)Phase 1/Phase 2
Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSLKazia Therapeutics LimitedPhase 2
Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSLLakshmi NayakPhase 2

See all GDC-0853 clinical trials

Clinical Trial Summary for GDC-0853

Top disease conditions for GDC-0853
Top clinical trial sponsors for GDC-0853

See all GDC-0853 clinical trials

US Patents for GDC-0853

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
GDC-0853 ⤷  Sign up for a Free Trial Heteroaryl pyridone and aza-pyrodine compounds Genentech, Inc. (South San Francisco, CA) ⤷  Sign up for a Free Trial
GDC-0853 ⤷  Sign up for a Free Trial Dosage form compositions comprising an inhibitor of bruton's tyrosine kinase Genentech, Inc. (South San Francisco, CA) ⤷  Sign up for a Free Trial
GDC-0853 ⤷  Sign up for a Free Trial Therapeutic compounds and compositions, and methods of use thereof Genentech, Inc. (South San Francisco, CA) ⤷  Sign up for a Free Trial
GDC-0853 ⤷  Sign up for a Free Trial Process for preparing BTK inhibitors Genentech, Inc. (South San Francisco, CA) ⤷  Sign up for a Free Trial
GDC-0853 ⤷  Sign up for a Free Trial Heteroaryl pyridone and aza-pyridone compounds Genentech, Inc. (South San Francisco, CA) ⤷  Sign up for a Free Trial
GDC-0853 ⤷  Sign up for a Free Trial Heteroaryl pyridone and aza-pyridone compounds Genentech, Inc. (South San Francisco, CA) ⤷  Sign up for a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for GDC-0853

Drugname Country Document Number Estimated Expiration Related US Patent
GDC-0853 Argentina AR088641 2031-11-03 ⤷  Sign up for a Free Trial
GDC-0853 Australia AU2012332365 2031-11-03 ⤷  Sign up for a Free Trial
GDC-0853 Australia AU2016273930 2031-11-03 ⤷  Sign up for a Free Trial
GDC-0853 Australia AU2018201557 2031-11-03 ⤷  Sign up for a Free Trial
GDC-0853 Australia AU2019216728 2031-11-03 ⤷  Sign up for a Free Trial
GDC-0853 Australia AU2020202707 2031-11-03 ⤷  Sign up for a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Medtronic
Baxter
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.